Quick answer
Dr. Jo Chan Ho, representative director of Cheongdam Cell Clinic, holds an MD, MSc and PhD from Hanyang University, currently serves as an attending professor at Hanyang University School of Medicine, sits as a director of the Korean Association of Stem Cell Therapy, and completed training at Brigham and Women's Hospital, Harvard University. A second physician, Dr. Park Young Seok, leads the clinic's pain-treatment work.
Cheongdam Cell Clinic publishes the education and academic standing of its doctors on the official 'About the Doctors' page, information patients can verify directly. The clinic's lead physician is Dr. Jo Chan Ho (조찬호), who serves as CEO and representative director.
On education, Dr. Jo completed his MD, MSc and PhD in medicine at Hanyang University. He also completed an MBA in Healthcare Management at the same university's graduate business school, and an Advanced Healthcare Management Program at Seoul National University Hospital.
The clinic also states Dr. Jo completed a Global Leadership Program at Seoul National University Graduate School of International Studies, an Anti-Aging Medicine program at CHA University Graduate School of Integrated Medicine, and training at Brigham and Women's Hospital, a Harvard-affiliated institution known for clinical research.
In current academic standing, Dr. Jo is an attending professor at Hanyang University School of Medicine, and previously held clinical professor posts at Sungkyunkwan University and The Catholic University of Korea, indicating teaching and clinical experience across multiple Korean medical institutions.
On professional societies, Dr. Jo is a director of the Korean Association of Stem Cell Therapy and a director of the Korean Association of Healthcare Management, alongside memberships in the Korean Association of Anti-aging Medicine, the Korean Association for Aesthetic Plastic Surgery, and the Korean Association for Laser Dermatology — spanning stem cell science, aesthetics and clinic administration.
Publications cited by the clinic include the research paper 'Binding of Cdc42 to phospholipase D1 is important in neurite outgrowth of neural stem cells', published in Biochemical and Biophysical Research Communications in 2006, concerning the growth mechanisms of neural stem cells. Dr. Jo is also the author of the book 'The Future of Korean Medical Tourism', published by Cheong Ram in 2010.
The clinic's second doctor, Dr. Park Young Seok (박영석), serves as clinic director and also holds an MD, MSc and PhD from Hanyang University. Dr. Park has completed specialised training in TPI (trigger point injection) and manual therapy, aligning with his role overseeing the 活(Vitality)CELL pain-treatment programme.
Before joining Cheongdam Cell Clinic, Dr. Park previously held a professorship at Kwandong University School of Medicine and an attending professor post at Korea University. He is a member of the Korean Association of Stem Cell Therapy, the Korean Association of Aesthetic Surgery, the Korean Association of Manual Medicine, and the Korean Association of Surgeons.
With both physicians holding training and academic appointments across Korean medical institutions, Cheongdam Cell Clinic positions itself as academically grounded. Even so, patients should always verify licensing details and the suitability of any treatment for their own health directly with the physician before proceeding.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.